Lecanemab Gains FDA Approval for Early Alzheimer Disease

被引：66
作者：
Larkin, Howard D. D.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 05期
关键词：
D O I：
10.1001/jama.2022.24490
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
[41]   FDA approval for Biogen's aducanumab sparks Alzheimer disease firestorm [J].
Mullard, Asher .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (07) :496-496
[42]   Lecanemab (Leqembi) for Alzheimer's Disease [J].
不详 .
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1669) :17-18
[43]   Lecanemab: Experts criticise European Commission approval of Alzheimer's drug [J].
Iacobucci, Gareth .
BMJ-BRITISH MEDICAL JOURNAL, 2025, 389 :r796
[44]   Levofloxacin gains US FDA approval to treat plague [J].
Purslow, Caroline .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (06) :629-629
[45]   Percutaneous heart valve gains US FDA approval [J].
不详 .
EXPERT REVIEW OF MEDICAL DEVICES, 2010, 7 (02) :171-171
[46]   Novartis gains US FDA approval to market Coartem® [J].
不详 .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (05) :504-504
[47]   Lecanemab: First Approval [J].
Sheridan M. Hoy .
Drugs, 2023, 83 :359-365
[48]   Lecanemab in the treatment of Alzheimer’s disease [J].
Peters O. ;
Nitschmann S. .
Die Innere Medizin, 2023, 64 (4) :406-408
[49]   Economic Evaluation of Lecanemab for Early Symptomatic Alzheimer's Disease in South Korea [J].
Shin, Seungyeon ;
Kim, Maryanne ;
Hong, Song Hee .
PHARMACOECONOMICS-OPEN, 2025,
[50]   New Alzheimer Drug Gains Full Approval [J].
Aschenbrenner, Diane S. .
AMERICAN JOURNAL OF NURSING, 2023, 123 (10) :23-23
12345